Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pyrazolo Isoquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot AgOTf catalyzed cyclization for pyrazolo[5,1-a]isoquinolines. High yield up to 90%, mild conditions, scalable for API intermediates.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Novel synthesis route for pyrazoloisoquinoline intermediates offers high yield and scalability for pharmaceutical manufacturing supply chains globally.